297 related articles for article (PubMed ID: 10332922)
1. Selenium and prostate cancer prevention.
Nelson MA; Porterfield BW; Jacobs ET; Clark LC
Semin Urol Oncol; 1999 May; 17(2):91-6. PubMed ID: 10332922
[TBL] [Abstract][Full Text] [Related]
2. Chemoprevention of prostate cancer with selenium: an update on current clinical trials and preclinical findings.
Meuillet E; Stratton S; Prasad Cherukuri D; Goulet AC; Kagey J; Porterfield B; Nelson MA
J Cell Biochem; 2004 Feb; 91(3):443-58. PubMed ID: 14755676
[TBL] [Abstract][Full Text] [Related]
3. Update on prostate cancer chemoprevention.
Lowe JF; Frazee LA
Pharmacotherapy; 2006 Mar; 26(3):353-9. PubMed ID: 16503715
[TBL] [Abstract][Full Text] [Related]
4. Review of vitamin E and selenium in the prevention of prostate cancer: implications of the selenium and vitamin E chemoprevention trial.
Pak RW; Lanteri VJ; Scheuch JR; Sawczuk IS
Integr Cancer Ther; 2002 Dec; 1(4):338-44. PubMed ID: 14664728
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological approaches to reducing the risk of prostate cancer.
Rittmaster RS; Fleshner NE; Thompson IM
Eur Urol; 2009 May; 55(5):1064-73. PubMed ID: 19200641
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of prostate cancer: agents and study designs.
Thompson IM
J Urol; 2007 Sep; 178(3 Pt 2):S9-S13. PubMed ID: 17644117
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of selenium chemoprevention and therapy in prostate cancer.
Nadiminty N; Gao AC
Mol Nutr Food Res; 2008 Nov; 52(11):1247-60. PubMed ID: 18727008
[TBL] [Abstract][Full Text] [Related]
8. Synergistic effect of vitamin E and selenium in human prostate cancer cell lines.
Venkateswaran V; Fleshner NE; Klotz LH
Prostate Cancer Prostatic Dis; 2004; 7(1):54-6. PubMed ID: 14745439
[TBL] [Abstract][Full Text] [Related]
9. Molecular targets of selenium in prostate cancer prevention (Review).
Abdulah R; Kobayashi K; Yamazaki C; Koyama H
Int J Oncol; 2011 Aug; 39(2):301-9. PubMed ID: 21567081
[TBL] [Abstract][Full Text] [Related]
10. Chemoprevention strategies for prostate cancer.
Bosland MC; McCormick DL; Melamed J; Walden PD; Zeleniuch-Jacquotte A; Lumey LH
Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S18-27. PubMed ID: 12570331
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer prevention: past, present, and future.
Fleshner N; Zlotta AR
Cancer; 2007 Nov; 110(9):1889-99. PubMed ID: 17893870
[TBL] [Abstract][Full Text] [Related]
12. Selenium, genetic variation, and prostate cancer risk: epidemiology reflects back on selenium and vitamin E cancer prevention trial.
Platz EA; Lippman SM
J Clin Oncol; 2009 Aug; 27(22):3569-72. PubMed ID: 19528369
[No Abstract] [Full Text] [Related]
13. Larry Clark's legacy: randomized controlled, selenium-based prostate cancer chemoprevention trials.
Marshall JR
Nutr Cancer; 2001; 40(1):74-7. PubMed ID: 11799927
[TBL] [Abstract][Full Text] [Related]
14. Chemoprevention of prostate cancer through dietary agents: progress and promise.
Syed DN; Khan N; Afaq F; Mukhtar H
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2193-203. PubMed ID: 18006906
[TBL] [Abstract][Full Text] [Related]
15. Prostate cancer chemoprevention by green tea.
Gupta S; Ahmad N; Mukhtar H
Semin Urol Oncol; 1999 May; 17(2):70-6. PubMed ID: 10332919
[TBL] [Abstract][Full Text] [Related]
16. Can prostate cancer be prevented?
Klein EA
Nat Clin Pract Urol; 2005 Jan; 2(1):24-31. PubMed ID: 16474573
[TBL] [Abstract][Full Text] [Related]
17. Selenium effects on prostate cell growth.
Menter DG; Sabichi AL; Lippman SM
Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1171-82. PubMed ID: 11097224
[TBL] [Abstract][Full Text] [Related]
18. Molecular chemoprevention by selenium: a genomic approach.
El-Bayoumy K; Sinha R
Mutat Res; 2005 Dec; 591(1-2):224-36. PubMed ID: 16099479
[TBL] [Abstract][Full Text] [Related]
19. Reduction in the risk of prostate cancer: future directions after the Prostate Cancer Prevention Trial.
Crawford ED; Andriole GL; Marberger M; Rittmaster RS
Urology; 2010 Mar; 75(3):502-9. PubMed ID: 20035983
[TBL] [Abstract][Full Text] [Related]
20. Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
Lee SO; Yeon Chun J; Nadiminty N; Trump DL; Ip C; Dong Y; Gao AC
Prostate; 2006 Jul; 66(10):1070-5. PubMed ID: 16637076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]